GSK
Live / Applied — Fourth extension granted (statement of use) (as of 06 Mar 2026)
What this means for you
Not registered yet, but its 07 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97446090
- Mark type
- Design + words
- Filed
- 07 Jun 2022
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes; medicated and sanitizing soaps and detergents
- Class 009 — Scientific and electric apparatus: Downloadable computer software for use in enabling healthcare professionals to access information on pharmaceutical and medical related products and services; downloadable computer software programs using artificial intelligence for use in machine learning
- Class 010 — Medical apparatus: Surgical apparatus and instruments for medical use; medical fluid injectors; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; transcutaneous electrical nerve stimulation devices to treat body pain; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyze data in real time and modulate neural signaling; drug delivery devices sold empty, namely, syringes for medical purposes and for injections; surgical implants comprising artificial material
- Class 035 — Advertising and business services: Advertising, marketing and promotional services; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; the provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, healthcare and fitness products through an on-line computer network; retail and wholesale store services featuring pharmaceuticals; distribution of advertising, marketing and promotional material
- Class 041 — Education and entertainment services: Educational services, namely, conducting classes in the field of pharmaceutical, diagnostic, vaccines, proprietary medicines, health, medical and skin care industries; educational services, namely, conducting seminars regarding health and health awareness and distributing course material in connection therewith; academic education, instruction and training, namely, conducting classes in the field of science, biotechnology, biology, health, health awareness and life sciences; conducting, organizing and arranging conferences, seminars and exhibitions for educational purposes in the field of medicine, health and wellness; publication of documents recorded on electronic storage media and on the internet in the field of scientific, medical diagnostic and technical laboratory matters and for research; training in the operation, repair and maintenance of scientific, surgical and medical devices and apparatus; publishing and issuing of scientific papers in the field of pharmaceuticals, diagnostic, vaccines, proprietary medicines, health, medical and skin care; provision of information, consultancy and advisory services relating to any of the aforesaid services
- Class 042 — Scientific and technological services: Scientific research for medical purposes in the field of pharmaceuticals, vaccines, cell and gene therapy; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting genetic testing for research purposes; scientific research consulting; medical laboratory services; Providing medical and scientific research information; computer system design services in the nature of design of computational models and systems of artificial intelligence; medical and pharmacological research services; software development, programming and implementation; research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services
- Class 044 — Medical, beauty and agricultural services: Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; gene and cell therapy medical treatment services; genetic testing for medical purposes; provision of information, consultancy and advisory services relating to any of the aforesaid services
Owner
- SmithKline Beecham Limited, London, GB
- SmithKline Beecham Limited, Brentford, Middlesex, GB
Prosecution history
- 07 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2026 — SOU EXTENSION 4 GRANTED
- 06 Mar 2026 — SOU EXTENSION 4 FILED
- 06 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 3 GRANTED
- 10 Sept 2025 — SOU EXTENSION 3 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 2 GRANTED
- 12 Mar 2025 — SOU EXTENSION 2 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED